skip to Main Content
What will legal cannabis sales look like in New York City? Not even the biggest dispensary chain in the US knows.

Cannabis has been legal in New York City since the end of March, but there’s still no way to legally purchase it.

What is expected to be America’s largest cannabis market is still stuck in limbo as New York legislators hammer out the details.

When will consumers be able to walk into a store and buy cannabis?

“We don’t know, we don’t know,” Patrik Jonsson, northeast regional president at Curaleaf, told Insider. “And not just on the timeline, but also what we’re going to be allowed to do,” he said.

Curaleaf is among the top cannabis MSOs, or multi-state operators, in the United States, according to The Motley Fool. It has over 100 dispensaries in 23 states, including New York State where it operates several medical dispensaries.

Jonsson is responsible for overseeing Curaleaf’s business in Connecticut, Maine, Maryland, Massachusetts, New Jersey, New York and Vermont. He said working on New York City right now is “kind of a moving target,” because it’s impossible to plan for the future without knowing what the regulations will be.

“We’re kind of hedging our bets on how big, how small, how quick,” Jonsson said. “‘Cause none of that is set in stone. We don’t know if we’re allowed to be in one location. Are we allowed two locations? Can it be three locations?” [Read More @ Business Insider]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

POSaBIT Buys Suite of Platforms (Leaf Data Systems, MJ Platform and Ample Organics) from Embattled Akerna Corp.

POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of  MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…

New York State now has 66 licensed cannabis retailers

New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…

FDA Says “No” to CBD Foods and Dietary Supplements

By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…

FDA finalizes guidance on cannabis clinical research

The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…

More Categories

Back To Top
×Close search
Search